ARDX ▲ +1.0% - Ardelyx, Inc.
$ARDX - Ardelyx Completes Enrollment in Phase 3 ACCEL Clinical Trial of IBSRELA® (tenapanor) in Adults with Chronic Idiopathic Constipation
03-NOV-2026 08:00 AM ET
Share this post
More filings for $ARDX
ARDX ▼ -3.8% - Ardelyx, Inc.Oct 23, 2026ARDX ▲ +0.9% - Ardelyx, Inc.Oct 12, 2026ARDX ▲ +0.6% - Ardelyx, Inc.Sep 30, 2026ARDX ▼ -0.3% - Ardelyx, Inc.Sep 1, 2026ARDX - Ardelyx, Inc. - SEC Filing Update (11-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 11, 2026
View full $ARDX filing history →💬 Comments
Loading comments…
Leave a comment